Ocular Trauma and COVID-19 in Indonesia

NCT06291844 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2024-03-04

No results posted yet for this study

Summary

Ocular injuries, a significant contributor to avoidable blindness globally, impact approximately 55 million individuals each year. Prompt initial treatment is vital for improving vision, yet the scarcity of skilled eye specialists often results in overcrowding at advanced medical centers. Moreover, the COVID-19 outbreak has introduced distinct factors into the management of ocular trauma. This research investigated the epidemiology of ocular injuries during the pandemic and offered observations on the distinctive hurdles and trends encountered.

Conditions

  • Ophthalmological Disorder
  • Ocular Injury
  • COVID-19

Sponsors & Collaborators

  • Prof. R. D. Kandou General Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-03-31
Completion
2023-06-01

Countries

  • Indonesia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06291844 on ClinicalTrials.gov